Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells

British Journal of Pharmacology

Volumn 154, Issue 4, 2008, Pages 852-863

  Lee, Y G ^a   Lee, W M ^b   Kim, J Y ^a   Lee, J Y ^a   Lee, I K ^c   Yun, B S ^c   Rhee, M H ^b   Cho, J Y ^a  

^a Kangwon National University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Anti inflammatory effect; Davallialactone; Inonotus xeranticus; Lipopolysaccharide; NF B; Src kinase

Indexed keywords

BETA GLUCAN; CD14 ANTIGEN; CYCLOOXYGENASE 2; DAVALLIALACTONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISPIDIN ANALOG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INONOBULIN A; INOSCAVIN A; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL PRODUCT; NITRIC OXIDE; PHELLIGRIDIN D; PHELLIGRIDIN F; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOPRECIPITATION; IMMUNOSTIMULATION; INFLAMMATION; INONOTUS XERANTICUS; MACROPHAGE; MEDIATOR RELEASE; MOUSE; MUSHROOM; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

AGARICALES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG DELIVERY SYSTEMS; INFLAMMATION; LACTONES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PHOSPHORYLATION; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 44949214708     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.136     Document Type: Article

References (40)

1. Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB (2002). Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J Immunol 169: 6490-6497.
2. Butchar JP, Parsa KV, Marsh CB, Tridandapani S (2006). Negative regulators of toll-like receptor 4-mediated macrophage inflammatory response. Curr Pharm Des 12: 4143-4153.
3. Cho JY, Baik KU, Jung JH, Park MH (2000). In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur J Pharmacol 398: 399-407.
4. Cho JY, Kim AR, Joo HG, Kim BH, Rhee MH, Yoo ES et al. (2004a). Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions. Biochem Biophys Res Commun 313: 954-961.
5. Cho JY, Park J, Kim PS, Yoo ES, Baik KU, Park MH (2001). Savinin, a lignan from Pterocarpus santalinus inhibits tumor necrosis factor-alpha production and T cell proliferation. Biol Pharm Bull 24: 167-171.
6. Cho JY, Park JS, Baik KU, Lee JG, Kim HP, Yoo ES et al. (2004b). Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritis. Pharmacol Res 49: 423-431.
7. Das J, Chen P, Norris D, Padmanabha R, Lin J, Moquin RV et al. (2006). 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl) -2-((6-(4-(2-hydroxyethyl)-1-piperazinyl))-2-methyl-4-pyrimidinyl)amino))-1, 3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. J Med Chem 49: 6819-6832.
8. Doggrell SA (2005). NF-kappa B - a target in the inflammation of bone destruction. Expert Opin Ther Targets 9: 191-193.
9. Dong Q, Jia LM, Fang JN (2006). A beta-D-glucan isolated from the fruiting bodies of Hericium erinaceus and its aqueous conformation. Carbohydr Res 341: 791-795.
10. Evans SE, Hahn PY, McCann F, Kottom TJ, Pavlovic ZV, Limper AH (2005). Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. Am J Respir Cell Mol Biol 32: 490-497.
11. Fishman P, Bar-Yehuda S, Madi L, Rath-Wolfson L, Ochaion A, Cohen S et al. (2006). The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Res Ther 8: R33.
12. Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL et al. (2001). Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 276: 39713-39720.
13. Hardy K, Hunt NH (2004). Effects of a redox-active agent on lymphocyte activation and early gene expression patterns. Free Radic Biol Med 37: 1550-1563.
14. Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R (2006). The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br J Pharmacol 149: 188-198.
15. Hong S, Kim SH, Rhee MH, Kim AR, Jung JH, Chun T et al. (2003). In vitro anti-inflammatory and pro-aggregative effects of a lipid compound, petrocortyne A, from marine sponges. Naunyn Schmiedebergs Arch Pharmacol 368: 448-456.
16. Jiang G, Zhang BB (2002). Pi 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes. Front Biosci 7: d903-d907.
17. Jung KK, Lee HS, Cho JY, Shin WC, Rhee MH, Kim TG et al. (2006). Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. Life Sci 79: 2022-2031.
18. Kamo T, Imura Y, Hagio T, Makabe H, Shibata H, Hirota M (2004). Anti-inflammatory cyathane diterpenoids from Sarcodon scabrosus. Biosci Biotechnol Biochem 68: 1362-1365.
19. Khadaroo RG, Kapus A, Powers KA, Cybulsky MI, Marshall JC, Rotstein OD (2003). Oxidative stress reprograms lipopolysaccharide signaling via Src kinase-dependent pathway in RAW 264.7 macrophage cell line. J Biol Chem 278: 47834-47841.
20. Kim HG, Shrestha B, Lim SY, Yoon DH, Chang WC, Shin DJ et al. (2006). Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol 545: 192-199.
21. Kim HY, Park EJ, Joe EH, Jou I (2003). Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 171: 6072-6079.
22. Kim SD, Lee IK, Lee WM, Cho JY, Park HJ, Oh JW et al. (2008). The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase. Eur J Pharmacol 584: 361-367.
23. Kobori M, Yoshida M, Ohnishi-Kameyama M, Shinmoto H (2007). Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. Br J Pharmacol 150: 209-219.
24. Lee HS, Moon C, Lee HW, Park EM, Cho MS, Kang JL (2007). Src tyrosine kinases mediate activations of NF-kappaB and integrin signal during lipopolysaccharide-induced acute lung injury. J Immunol 179: 7001-7011.
25. Lee IK, Seok SJ, Kim WK, Yun BS (2006). Hispidin derivatives from the mushroom Inonotus xeranticus and their antioxidant activity. J Nat Prod 69: 299-301.
26. Lee IK, Yun BS (2006). Hispidin analogs from the mushroom Inonotus xeranticus and their free radical scavenging activity. Bioorg Med Chem Lett 16: 2376-2379.
27. Lee JY, Lowell CA, Lemay DG, Youn HS, Rhee SH, Sohn KH et al. (2005). The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4. Biochem Pharmacol 70: 1231-1240.
28. Leu TH, Charoenfuprasert S, Yen CK, Fan CW, Maa MC (2006). Lipopolysaccharide-induced c-Src expression plays a role in nitric oxide and TNFalpha secretion in macrophages. Mol Immunol 43: 308-316.
29. Lull C, Wichers HJ, Savelkoul HF (2005). Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm 2005: 63-80.
30. Malyshev IY, Shnyra A (2003). Controlled modulation of inflammatory, stress and apoptotic responses in macrophages. Curr Drug Targets Immune Endocr Metabol Disord 3: 1-22.
31. Merlini L, Nasini G, Scaglioni L, Cassinelli G, Lanzi C (2000). Structure elucidation of clavilactone D: an inhibitor of protein tyrosine kinases. Phytochemistry 53: 1039-1041.
32. Nam NH (2006). Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6: 945-951.
33. Okkenhaug K, Vanhaesebroeck B (2001). New responsibilities for the PI3K regulatory subunit p85 alpha. Sci STKE 2001: PE1.
34. Palaniyar N, Nadesalingam J, Reid KB (2002). Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands. Immunobiology 205: 575-594.
35. Park J, Hill MM, Hess D, Brazil DP, Hofsteenge J, Hemmings BA (2001). Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 and their role in regulating kinase activity. J Biol Chem 276: 37459-37471.
36. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS (1996). Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 156: 3435-3442.
37. Smolinska MJ, Horwood NJ, Page TH, Smallie T, Foxwell BM (2008). Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages. Mol Immunol 45: 990-1000.
38. Sorensen HR, Meyer AS, Pedersen S (2003). Enzymatic hydrolysis of water-soluble wheat arabinoxylan. 1. Synergy between alpha-L- arabinofuranosidases, endo-1,4-beta-xylanases, and beta-xylosidase activities. Biotechnol Bioeng 81: 726-731.
39. Wang Y, Shang XY, Wang SJ, Mo SY, Li S, Yang YC et al. (2007). Structures, biogenesis, and biological activities of pyrano(4,3-c) isochromen-4-one derivatives from the Fungus Phellinus igniarius. J Nat Prod 70: 296-299.
40. Yoshimura A (2006). Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 97: 439-447.